Epstein Secrets

ML) 400MG/5ML Exp: 10/28/2019 SIG: shake well take 10ml by daily AS NEEDED Omega 3 (Vascepa) 1 GM Capsule Exp: 01/13/2020 SIG: Take two capsules (2 GM) twice daily by OTCs: Listing of all known OTCs this Inmate is currently taking. None Pending Appointments Dabs lima Activity Provider 07/24/

28:51 76318-054 REG REGNO: 76318-054 FUNCTION: PAT DOB/AGE.: 01-20-1953 / 66 NAME.: EPSTEIN, JEFFREY EDWARD R/S/ETH.: W/M/O WALSH: YES RSP..: NYM-NEW YORK MCC MILEAGE.: 5 MILES PHONE: 646-836-6300 FAX: 646-836-7751 ARS ASSIGNMENT..: ESC TRP TO LOC HOSP W/RETN-USM FBI NO..: ARS DATE/TIME...: 08-10-2019/

L Exp: 10/28/2019 SIG: shake well take 10mI by mouth twice daily AS NEEDED Omega 3 (Vascepa) 1 GM Capsule Exp: 01/13/2020 SIG: Take two capsules (2 GM) twice daily by mouth with food OTCs: Listing of all known OTCs this inmate is currently taking. None Pending Appointments A(ga Time Activity 0

ing my expressed wishes and directions. BEAUDOUIN, ROBERT MD 7-24-2019 Counseled by Dale Signature of Wine S Date —71,ceock/c 6 6-e6ers /re NYM-NEW YORK MCC 1 EFTA00049727 BP-A0618 JUN 16 U.S. DEPARTMENT OF JUSTICE A&O DENTAL EXAMINATION (Initial Clinical Dental Findings) FEDERAL BUREAU OF PRISON

L Exp: 10/28/2019 SIG: shake well take 10ml by mouth twice daily AS NEEDED Omega 3 (Vascepa) 1 GM Capsule Exp: 01/13/2020 SIG: Take two capsules (2 GM) twice daily by mouth with food OTCs: Listing of all known OTCs this inmate is currently taking. None Pending Appointments Date Time Activity

nd following my expressed wishes and directions. BEAUDOUI , ROBERT MD 7-24-2019 Counseled by Date Signature of Witn s Date cG 7 -4;c6e6 tej- NYM-NEW YORK MCC EFTA00045863 BP-S358.060 SLP 05 MEDICAL TREATMENT REFUSAL CDFRM U.S. DEPARTMENT OF JUSTICE FEDERAL BUREAU OF PRISONS 7-10-2019 Date I, JEF

tion Orders: M Medication Omega 3 ( Vascepa) 1 GM Capsule Indication: Hyperlipidemia, unspecified

all liability for respecting and following my expressed wishes and directions. b)/6): (b)(7)1C) 7-24-2019 Date ig~ Date (b)(6): {b)(7)(C) s NYM-NEW YORK MCC I I I l l f t ( } I .. i Page 2398 I BP-S358.060 SEP OS MEDICAL TREATMENT REFUSAL CDFRM U.S. DEPARTMENT OF JUSTICE FEDERAL BUREAU OF